Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
CNY 8.12
(10.03%)
CNY 8.12
(10.03%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.61 Billion CNY | 0.85% |
| 2022 | 1.6 Billion CNY | 0.39% |
| 2021 | 1.59 Billion CNY | -1.17% |
| 2020 | 1.61 Billion CNY | -1.1% |
| 2019 | 1.63 Billion CNY | -2.72% |
| 2018 | 1.67 Billion CNY | 0.79% |
| 2017 | 1.66 Billion CNY | 2.74% |
| 2016 | 1.62 Billion CNY | 11.95% |
| 2015 | 1.44 Billion CNY | 19.52% |
| 2014 | 1.21 Billion CNY | 154.86% |
| 2013 | 475.55 Million CNY | 143.53% |
| 2012 | 195.28 Million CNY | 45.91% |
| 2011 | 133.83 Million CNY | 35.84% |
| 2010 | 98.52 Million CNY | 43.15% |
| 2009 | 68.82 Million CNY | -2.98% |
| 2008 | 70.93 Million CNY | 13.95% |
| 2007 | 62.25 Million CNY | 5.12% |
| 2006 | 59.22 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.63 Billion CNY | 0.74% |
| 2024 Q3 | 1.62 Billion CNY | -0.43% |
| 2024 Q1 | 1.62 Billion CNY | 0.27% |
| 2023 Q3 | 1.61 Billion CNY | 1.23% |
| 2023 Q1 | 1.59 Billion CNY | -0.68% |
| 2023 FY | 1.61 Billion CNY | 0.85% |
| 2023 Q4 | 1.61 Billion CNY | 0.19% |
| 2023 Q2 | 1.59 Billion CNY | 0.12% |
| 2022 Q3 | 1.6 Billion CNY | 1.03% |
| 2022 Q1 | 1.59 Billion CNY | -0.21% |
| 2022 Q4 | 1.6 Billion CNY | 0.05% |
| 2022 FY | 1.6 Billion CNY | 0.39% |
| 2022 Q2 | 1.58 Billion CNY | -0.47% |
| 2021 Q1 | 1.6 Billion CNY | -0.37% |
| 2021 Q2 | 1.61 Billion CNY | 0.29% |
| 2021 Q3 | 1.6 Billion CNY | -0.3% |
| 2021 FY | 1.59 Billion CNY | -1.17% |
| 2021 Q4 | 1.59 Billion CNY | -0.8% |
| 2020 Q1 | 1.62 Billion CNY | -0.38% |
| 2020 Q2 | 1.63 Billion CNY | 0.72% |
| 2020 Q3 | 1.62 Billion CNY | -0.64% |
| 2020 Q4 | 1.61 Billion CNY | -0.8% |
| 2020 FY | 1.61 Billion CNY | -1.1% |
| 2019 Q2 | 1.65 Billion CNY | -0.74% |
| 2019 Q1 | 1.66 Billion CNY | -0.8% |
| 2019 FY | 1.63 Billion CNY | -2.72% |
| 2019 Q3 | 1.65 Billion CNY | 0.18% |
| 2019 Q4 | 1.63 Billion CNY | -1.39% |
| 2018 Q1 | 1.67 Billion CNY | 0.27% |
| 2018 FY | 1.67 Billion CNY | 0.79% |
| 2018 Q4 | 1.67 Billion CNY | -1.82% |
| 2018 Q3 | 1.71 Billion CNY | 1.24% |
| 2018 Q2 | 1.68 Billion CNY | 1.13% |
| 2017 Q2 | 1.65 Billion CNY | 1.93% |
| 2017 Q3 | 1.68 Billion CNY | 1.48% |
| 2017 Q4 | 1.66 Billion CNY | -0.95% |
| 2017 FY | 1.66 Billion CNY | 2.74% |
| 2017 Q1 | 1.62 Billion CNY | 0.27% |
| 2016 Q4 | 1.62 Billion CNY | -0.47% |
| 2016 Q3 | 1.62 Billion CNY | 0.71% |
| 2016 Q2 | 1.61 Billion CNY | 8.16% |
| 2016 FY | 1.62 Billion CNY | 11.95% |
| 2016 Q1 | 1.49 Billion CNY | 3.26% |
| 2015 FY | 1.44 Billion CNY | 19.52% |
| 2015 Q2 | 1.29 Billion CNY | -3.01% |
| 2015 Q1 | 1.33 Billion CNY | 10.26% |
| 2015 Q4 | 1.44 Billion CNY | 8.27% |
| 2015 Q3 | 1.33 Billion CNY | 3.22% |
| 2014 Q3 | 695.98 Million CNY | -3.14% |
| 2014 Q1 | 684.32 Million CNY | 43.9% |
| 2014 FY | 1.21 Billion CNY | 154.86% |
| 2014 Q4 | 1.21 Billion CNY | 74.14% |
| 2014 Q2 | 718.54 Million CNY | 5.0% |
| 2013 Q3 | 359.53 Million CNY | 25.82% |
| 2013 Q2 | 285.75 Million CNY | 41.82% |
| 2013 Q1 | 201.49 Million CNY | 3.18% |
| 2013 FY | 475.55 Million CNY | 143.53% |
| 2013 Q4 | 475.55 Million CNY | 32.27% |
| 2012 Q4 | 195.28 Million CNY | 1.85% |
| 2012 Q3 | 191.72 Million CNY | 40.09% |
| 2012 Q2 | 136.85 Million CNY | 4.75% |
| 2012 Q1 | 130.64 Million CNY | -2.39% |
| 2012 FY | 195.28 Million CNY | 45.91% |
| 2011 Q3 | 143.67 Million CNY | 20.2% |
| 2011 FY | 133.83 Million CNY | 35.84% |
| 2011 Q2 | 119.53 Million CNY | 12.93% |
| 2011 Q1 | 105.85 Million CNY | 7.44% |
| 2011 Q4 | 133.83 Million CNY | -6.85% |
| 2010 Q4 | 98.52 Million CNY | 0.0% |
| 2010 FY | 98.52 Million CNY | 43.15% |
| 2009 FY | 68.82 Million CNY | -2.98% |
| 2009 Q2 | 68.87 Million CNY | 0.0% |
| 2009 Q4 | 68.82 Million CNY | 0.0% |
| 2008 FY | 70.93 Million CNY | 13.95% |
| 2007 FY | 62.25 Million CNY | 5.12% |
| 2006 FY | 59.22 Million CNY | 0.0% |